Milontin (TN)
Milontin (TN) Brand names, Milontin (TN) Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
Milontin (TN) Brand Names Mixture
- No information avaliable
Milontin (TN) Chemical_Formula
C11H11NO2
Milontin (TN) RX_link
No information avaliable
Milontin (TN) fda sheet
Milontin (TN) msds (material safety sheet)
Milontin (TN) Synthesis Reference
No information avaliable
Milontin (TN) Molecular Weight
189.211 g/mol
Milontin (TN) Melting Point
72 oC
Milontin (TN) H2O Solubility
7020 mg/L
Milontin (TN) State
Solid
Milontin (TN) LogP
1.079
Milontin (TN) Dosage Forms
Capsules
Milontin (TN) Indication
For the treatment of epilepsy
Milontin (TN) Pharmacology
Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
Milontin (TN) Absorption
Rapid and complete
Milontin (TN) side effects and Toxicity
No information avaliable
Milontin (TN) Patient Information
No information avaliable
Milontin (TN) Organisms Affected
Humans and other mammals
